California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on August 3, 2026

Aug. 3, 2026

Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH

Indeterminate GlobeNewswire

Aug. 3, 2026

Design Therapeutics Provides RESTORE-FA Clinical Development Update and Reports Second Quarter 2026 Financial Results 

Indeterminate GlobeNewswire

Aug. 3, 2026

Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

Akebia Therapeutics Announces Initiation of a Phase 2 Basket Trial to Study Ebribafusp, a Next-Generation Complement Inhibitor in Rare Kidney Diseases

Indeterminate GlobeNewswire

Aug. 3, 2026

Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation

Indeterminate GlobeNewswire

Aug. 3, 2026

electroCore to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Aug. 3, 2026

Helus Pharma Appoints Michael Halstead as Chief Executive Officer

Indeterminate GlobeNewswire

Aug. 3, 2026

Curium Announces Definitive Agreement to Merge with Lantheus

Indeterminate GlobeNewswire

Aug. 3, 2026

BridgeBio to Report Second Quarter 2026 Financial Results and Commercial Updates on August 10, 2026 at 4:30 pm ET

Indeterminate GlobeNewswire

Aug. 3, 2026

ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 3, 2026

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 3, 2026

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Aug. 3, 2026

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Indeterminate GlobeNewswire

Aug. 3, 2026

Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA® (arimoclomol) in Niemann-Pick Disease Type C (NPC)

Indeterminate GlobeNewswire

Aug. 3, 2026

Veritasium Goes Behind the Scenes at Kraig Biocraft Laboratories to Explore the Future of Commercial Spider Silk

Indeterminate GlobeNewswire

Aug. 3, 2026

Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health

Indeterminate GlobeNewswire

Aug. 3, 2026

Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

Aug. 3, 2026

Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System

Indeterminate GlobeNewswire

Aug. 3, 2026

Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia

Indeterminate GlobeNewswire

Aug. 3, 2026

Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire